Bio Medica Laboratories Limited — Shareholders meeting

Bio Medica Laboratories Limited has announced that its Annual General Meeting (AGM) is scheduled to take place on September 28, 2026. This formal notice has been submitted to the stock exchange, marking a standard corporate governance step for the company. The AGM serves as the primary forum for the board of directors to present the financial performance for the previous year and seek approval from the shareholders on key resolutions.

For investors, this meeting is significant as it provides a scheduled opportunity to review the company's strategic direction and financial health. The agenda typically includes the approval of annual accounts, dividend declarations, and the election of directors. While the specific agenda items are not detailed in this notice, the event is a routine part of the corporate calendar that ensures transparency and accountability for the company's management.